PJRC(SH:600395)2019-10-28 16:00Financial Performance - Net profit attributable to shareholders was CNY 896,132,604.25, representing a year-on-year increase of 23.37%[8] - Operating revenue for the first nine months was CNY 4,943,803,674.93, up 11.26% from the same period last year[8] - Basic earnings per share rose to CNY 0.541, an increase of 23.235% year-on-year[8] - The weighted average return on equity increased by 2.413 percentage points to 13.181%[8] - The company reported a total sales revenue of 4.75 billion yuan from its main products, with a gross profit of approximately 1.76 billion yuan[19] - Total operating revenue for Q3 2019 reached ¥1.61 billion, compared to ¥1.47 billion in Q3 2018, marking an increase of 10.5%[105] - Net profit for Q3 2019 was ¥274,628,394.90, compared to ¥199,462,795.64 in Q3 2018, representing a growth of 37.7%[100] - The company's net profit attributable to shareholders for Q3 2019 was approximately ¥274.63 million, an increase from ¥198.84 million in Q3 2018, representing a growth of 38.2%[104] - The company reported a total comprehensive income for Q3 2019 of approximately ¥258.82 million, compared to ¥194.54 million in Q3 2018, an increase of 33.0%[109] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 14,112,519,697.03, an increase of 7.50% compared to the end of the previous year[8] - The company's current assets reached CNY 5.29 billion, up from CNY 4.82 billion year-over-year, indicating an increase of approximately 9.76%[25] - Total liabilities increased to CNY 6.70 billion from CNY 6.23 billion, marking a rise of approximately 7.52%[25] - The company's equity attributable to shareholders rose to CNY 7.09 billion, compared to CNY 6.57 billion, reflecting an increase of about 8.06%[25] - The total current liabilities reached CNY 4.11 billion, up from CNY 3.87 billion, representing an increase of about 6.00%[25] - The company's long-term liabilities were CNY 2,364,891,204.24, slightly up from CNY 2,335,259,651.52[154] - The total liabilities amounted to CNY 6,230,787,037.88, an increase from CNY 6,201,155,485.16[154] Cash Flow - Net cash flow from operating activities increased by 50.42% to CNY 1,315,438,872.45 compared to the previous year[8] - In the first three quarters of 2019, the company generated cash inflows from operating activities amounting to CNY 4,861,379,841.34, an increase of 6.73% compared to CNY 4,553,577,065.71 in the same period of 2018[111] - The net cash flow from operating activities for the first three quarters of 2019 was CNY 1,315,438,872.45, significantly higher than CNY 874,512,730.93 in the previous year, reflecting a growth of 50.5%[111] - The total cash and cash equivalents at the end of the reporting period reached CNY 1,831,652,429.18, up from CNY 1,203,462,239.24 at the end of the same period in 2018[113] - Cash flow from financing activities totaled CNY 1,217,000,000, a decrease of 26.7% compared to CNY 1,661,911,251.62 in the previous period[117] - Net cash flow from financing activities was negative CNY 304,807,062.90, contrasting with a positive CNY 14,342,060.26 in the prior year[117] Other Financial Metrics - The company reported a loss of CNY 16,207.50 from the disposal of non-current assets during the reporting period[10] - Government subsidies recognized in the current period amounted to CNY 383,174.85, contributing to the overall financial performance[10] - Cash and cash equivalents increased by 45.16% to CNY 1,989,048,459.91 compared to the beginning of the year, primarily due to increased cash collections and maturity of notes[13] - Research and development expenses surged to ¥71,069,217.33 in Q3 2019, significantly higher than ¥2,381,430.61 in Q3 2018[100] - The company’s financial expenses increased to ¥26.73 million in Q3 2019 from ¥21.67 million in Q3 2018, indicating a rise of 23.5%[105]